Bone Biologics Corp cotiza a 0.41 USD y tiene una capitalización bursátil de $1M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company a…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-0.43 | $-0.63 | $-0.37 | $-1.33 |
| Estimado | $-0.54 | $-0.34 | $-1.23 | $-0.58 |
| Sorpresa | +20.4% | -85.3% | +69.9% | -129.3% |
| Métrica | BBLG | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -57.8% | -40.4% | -17.4% |
| ROA | -53.6% | -32.0% | -21.6% |
| Current Ratio | 13.85 | 2.84 | +11.01 |
| Debt / Equity | — | 0.28 | — |